Lunit Demonstrates Progress in the Development of Novel Diagnostics at the 2023 AACR Annual Meeting
- Written by PR Newswire
![]() |
- Lunit and collaborators demonstrate key progress in the development of novel diagnostics for cancer therapies, including immuno-oncology, in addition to molecular targeted agents and antibody-drug conjugates
- Presentations to deliver new research using Lunit SCOPE in a wide range of cancer types and treatment settings
SEOUL, South Korea, April 11,...















